Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder

NCT06592833 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Psilocybin
DRUG: Pimavanserin
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai